KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Convertible Debt (2016 - 2022)

Supernus Pharmaceuticals has reported Convertible Debt over the past 10 years, most recently at $400.4 million for Q1 2022.

  • Quarterly Convertible Debt rose 9.38% to $400.4 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $400.4 million through Mar 2022, up 9.38% year-over-year, with the annual reading at $379.3 million for FY2021, 4.84% up from the prior year.
  • Convertible Debt was $400.4 million for Q1 2022 at Supernus Pharmaceuticals, up from $379.3 million in the prior quarter.
  • Over five years, Convertible Debt peaked at $400.4 million in Q1 2022 and troughed at $318.2 million in Q1 2018.
  • The 5-year median for Convertible Debt is $349.2 million (2020), against an average of $350.9 million.
  • Year-over-year, Convertible Debt soared 21769.57% in 2018 and then grew 4.74% in 2019.
  • A 5-year view of Convertible Debt shows it stood at $329.5 million in 2018, then increased by 4.77% to $345.2 million in 2019, then rose by 4.8% to $361.8 million in 2020, then grew by 4.84% to $379.3 million in 2021, then rose by 5.57% to $400.4 million in 2022.
  • Per Business Quant, the three most recent readings for SUPN's Convertible Debt are $400.4 million (Q1 2022), $379.3 million (Q4 2021), and $374.8 million (Q3 2021).